hydroxychloroquine has been researched along with Infection Reactivation in 1 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The treatment with hydroxychloroquine probably explains the decreased immune response with negative serology and subsequent reinfection in our patient." | 1.62 | Symptomatic severe acute respiratory syndrome coronavirus 2 reinfection in a lupus patient treated with hydroxychloroquine: a case report. ( Anthierens, T; Bartiaux, M; Goldberg, O; Maes, P; Muyldermans, A; Piérard, D; Soetens, O; Van den Wijngaert, S; Wawina-Bokalanga, T; Wybo, I, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muyldermans, A | 1 |
| Maes, P | 1 |
| Wawina-Bokalanga, T | 1 |
| Anthierens, T | 1 |
| Goldberg, O | 1 |
| Bartiaux, M | 1 |
| Soetens, O | 1 |
| Wybo, I | 1 |
| Van den Wijngaert, S | 1 |
| Piérard, D | 1 |
1 other study available for hydroxychloroquine and Infection Reactivation
| Article | Year |
|---|---|
Symptomatic severe acute respiratory syndrome coronavirus 2 reinfection in a lupus patient treated with hydroxychloroquine: a case report.
Topics: Antiviral Agents; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Middle Aged; Reinfection; SAR | 2021 |